Delivery Order SPE2DB24D9131-SPE2DB24FXRP0

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with an ultimate completion date of September 6, 2024, is for the supply of XTANDI 40 MG TABLET 120S. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a $4,169.59 firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract valued up to $499,999,999. The award covers the supply of the pharmaceutical product XTANDI 40 MG TABLET 120S to support the recurring medical needs of the Department of Defense's (DoD) healthcare facilities worldwide. DMS Pharmaceutical Group is a key...
The U.S. government awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,695.90 contract, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division, is for the delivery of the medication XTANDI 40 MG TABLET 120S. This contract award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XTANDI 40 MG CAPSULE 120S, with a period of performance through August 12, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,321.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 1, 2022, is for the supply of 4557937756 - XTANDI 40 MG CAPSULE 120S. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with DMS Pharmaceutical Group, which runs...
This federal contract award, valued at $4,311.35, was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order under DMS Pharmaceutical Group's existing Indefinite Delivery Vehicle (IDV) contract SPE2DB, which has a ceiling value of up to $4,999,999 through the end of 2025. This IDV allows DLA to issue firm fixed-price delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 5, 2024, is for the delivery of XTANDI 80 MG TABLET 60S, a pharmaceutical product. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of...
The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order worth $25,868.10 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The order is for 120 capsules of the pharmaceutical product XTANDI 40 MG and has a completion date of February 7, 2024. This order is placed under DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the DLA, valued at up to $4,999,999 through 2025, which enables the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $8,339.18 for the supply of XTANDI 40 MG TABLET 120S, a prescription medication. The contract has a firm fixed-price pricing type and an ultimate completion date of January 31, 2025. DMS Pharmaceutical Group Inc. also holds a significant single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,508.77 firm fixed-price delivery order is for the supply of XTANDI 40 MG TABLET 120S, a pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue...
  • SPE2DB24D9131
    Indefinite Delivery Contract
  • SPE2DB24D9131-SPE2DB24FXRP0
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB medical supply program. The $8,339.18 contract provides the DLA with 4,565,213,041 units of the drug XTANDI 40 MG TABLET 120S. The contract has no set-aside designation and a completion date of July 22, 2024. DMS Pharmaceutical Group specializes in supplying a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA), and holds a significant $499,999,999 indefinite delivery contract with the DLA under the SPE2DB program to fulfill the recurring medical supply needs of military health facilities worldwide.

Generated 10/18/24, 9:11 AM